Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Surgical Procedures, Operative × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hepatic Veno-Occlusive Disease 1 Head and Neck Neoplasms 1 HER2-positive Early Breast Cancer 1

Interventions

Specimen Handling 6 Cyclophosphamide 5 Biopsy 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 X-Rays 3 Trabectedin 3 regorafenib 2 pembrolizumab 2 pazopanib 2 fludarabine 2 atezolizumab 2 Radiation 2 Phantoms, Imaging 2 Metastasectomy 2 Interleukin-15 2 Ifosfamide 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 trastuzumab deruxtecan 1 tivozanib 1 tazemetostat 1 talimogene laherparepvec 1 selinexor 1 pimonidazole 1 perflutren 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05950594 2026-03-16

IVIM & OLINK in Sarcoma

University Health Network, Toronto

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡